There could be adverse effects on the baby's growth inside the womb
Published Phase 2 trial data for retatrutide (Jastreboff et al., NEJM , 2023) demonstrated significant reductions in body weight and improvements in cardiometabolic markers
Fei Y, Tsoi M-F, Cheung BMY
However, it is important to remember that using the drugs to suppress appetite doesnt just contribute to fat loss but also to reduced muscle mass
Gao, X., et al., Efficacy and safety of semaglutide on weight loss in obese or overweight patients without diabetes: A systematic review and meta-analysis of randomized controlled trials
By moving beyond a superficial understanding of its benefits and embracing the complex science of its mechanism, users can unlock a new tier of proactive health management